- Crude Oil Inventory Change: 6.93m bbl (Expected: 0.5m bbl; Previous: 6.16m bbl)
-
Gasoline Inventory Change: -2.59m bbl (Expected: -2.1m bbl; Previous: -5.44m bbl)
-
Distillate Inventory Change: 3.03m bbl (Expected: -1.4m bbl; Previous: -2.53m bbl)
US crude inventories have recorded another sharp increase, though this is partially offset by another significant draw in gasoline stocks. Yesterday’s API report had estimated a more modest crude build of 2.3m bbl. Notably, refinery utilization rose by 1.5 percentage points; therefore, the decline in gasoline inventories points to resilient demand, while the rise in distillates suggests the end of the heating season. Despite these figures, the report has had little impact on oil prices, which remain primarily driven by developments in Iran.
WTI crude is finding support near $88 per barrel at the 25-period moving average. Iran's rejection of peace terms indicates that tensions in the Middle East will remain high for the foreseeable future. At the same time, continued pressure from the US suggests that Washington is keen to avoid a prolonged conflict, which has been driving up commodity prices and generating massive economic costs.
Chart of the day 🚩VIX surges 2.5% amid increasing stock market uncertainty (26.03.2026)
Consumer sentiments fall in Germany and France amid rising energy prices
Morning wrap: Stock market indices slide as oil jumps to $100 again (26.03.2026)
Daily Summary: Iran Uninterested in Trump’s Peace Plan
The material on this page does not constitute as financial advice and does not take into account your level of understanding, investment objectives, financial situation or any other particular needs.
All the information provided, including opinions, market research, mathematical results and technical analyses published on the website or transmitted to you by other means is provided for information purposes only and should in no event be interpreted as an offer of, or solicitation for, a transaction in any financial instrument, nor should the information provided be construed as advice of legal or fiscal nature.
Any investment decisions you make shall be based exclusively on your level of understanding, investment objectives, financial situation or any other particular needs. Any decision to act on information published on the website or transmitted to you by other means is entirely at your own risk. You are solely responsible for such decisions.
If you are in doubt or are not sure that you understand a particular product, instrument, service, or transaction, you should seek professional or legal advice before trading.
Investing in OTC Derivatives carries a high degree of risk, as they are leveraged based products and often small movements in the market could lead to much larger movements in the value of your investment and this could work against you or for you. Please ensure that you fully understand the risks involved, taking into account your investments objectives and level of experience, before trading, and if necessary, seek independent advice.
